1050979

Alnylam Pharmaceuticals, Inc. — FEI 3004080452

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 25, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cambridge, MA (United States)

Additional Details

Sponsor, Contract Research Organization